Document is current
Any future updates will be listed below
-
Authors
Cappelle, Sarah
Pareto, Deborah
Tintoré, Mar
Vidal-Jordana, Angela
Alyafeai, Rumaiza
Alberich, Manel
Sastre-Garriga, Jaume
Auger, Cristina
Montalban, Xavier
Rovira, Àlex
- License Information
-
More Information
Article History
Received: 31 December 2019
Accepted: 10 March 2020
First Online: 3 April 2020
Compliance with ethical standards
:
: S. Cappelle declares that she has no conflict of interest. D. Pareto has received a speaker honorarium from Novartis and Sanofi-Genzyme. M. Tintoré has received a speaker honorarium and travel expenses for participation in scientific meetings or advisory boards in past years from Almirall, Bayer, Biogen, EMD Serono, Genzyme, Merck, Novartis, Roche, Sanofi-Genzyme, Teva Pharmaceutical, VielaBio, and Excemed. A. Vidal-Jordana has received honoraria as speaker and/or for participation in Advisory Boards from Novartis, Roche, Sanofi-Genzyme, and Biogen. R. Alyafeai has been awarded the McDonald fellowship from MSIF. M. Alberich declares that he has no conflict of interest. J. Sastre-Garriga has received grants and personal fees from Genzyme, personal fees from Almirall, Biogen, Celgene, Merck, Novartis, Roche, and Teva. He declares being a member of the Editorial Committee of the MS Journal for which he receives a personal fee and Director of the Scientific Committee of Revista de Neurología, for which he does not receive any personal fee. C. Auger declares that she has no conflict of interest. X. Montalban has received a speaker honorarium and travel expenses for participation in scientific meetings or advisory boards in past years from Actelion, Alexion, Bayer, Biogen, Celgene, EMD Serono, Genzyme, Medday, Merck, Nervgen, Novartis, Roche, Sanofi-Genzyme, Teva Pharmaceutical, TG Therapeutics, Excemed, MSIF, and NMSS. A. Rovira has received a speaker honorarium from Bayer, Sanofi-Genzyme, Bracco, Merck-Serono, Teva Pharmaceutical Industries Ltd., Novartis, Roche, and Biogen. He serves on scientific advisory boards for Novartis, Sanofi-Genzyme, SyntheticMR, Bayer, Roche, Biogen, Neurodiem, and OLEA Medical.
: This study was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
